Winter 2024 Investor Summit Virtual

40 MicroCap Presenters – November 21, 2024

9:00am-4:00pm ET – Company Presentations
8:00am-4:00pm – 1×1 Meetings

Q4 Presenters

TNXP

Tonix submitted a New Drug Application to the FDA in October 2024.
An FDA decision on the NDA is expected in 2025, with potential product launch in 2025 if approved.

URG

Largest U.S. uranium miner
Nuclear energy sector is in rapid growth

TMGEF

Proprietary energy efficiency solutions provide high ROI
Track record of profitable growth with significant repeat business from F500

TGCB

Product, people, plan, opportunity = success
Commercial success is in process

MFIN

MFIN has a proven track record of growing loan portfolio.
Above average NIM gives flexibility and options.

MAIA

Unprecedented efficacy clinical data in current clinical trial with a supply agreement with Regeneron. Ongoing discussions with potential major pharma partners for next trials
One of the most undervalued biotech stocks in Oncology: analysts project $10-14/share in 2025; analogs suggest $50-

Timing of self-checkout, specifically Smart cart adoption, is starting to broadly happen among more and more grocery chains. Strong momentum with notable international and domestic grocery store and wholesale chains. Rollout and implementation of our smart carts to commence in earnest in Q1.
Publicly announced two IT partnerships that represent two

NMTC

Thin-film electrode platform technology with multiple market opportunities treating and diagnosing neurological disorders and pain.
Improving financial profile. Now have 3 product families commercialized in the United States.

NRBO

Targeting Obesity and MASH with a Pipeline of Next Generation Therapeutics
Aiming to increase Shareholder Value through Multiple, Near-Term, Value Creating Milestones DA-1726

IMUX

Immunic is developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases
Top-line data from the phase 2 CALLIPER trial of vidofludimus calcium in PMS is expected in April 2025

BLGO

Has a proven business model of inventing, proving, and partnering out its innovative environmental technologies, highlighted by the blockbuster success of its pet odor control product Pooph.
Has innovations in high-yield, rapidly growing markets like battery energy storage and PFAS treatment that are superior to existing solutions in the market.

SOTK

Consistently profitable with strong growth trajectory in disruptive high tech markets.
Record revenue in Fiscal year 2024, 30% YOY growth.

ACFN

Liquidity of the shares will improve with performance and as the price increases towards intrinsic value.
Acorn's results are just starting to reflect a large contract with a leading Telecom provider.

OESX

FY’25 revenue expected to increase 10% weighted toward the 2H.
EV charging grew 40% in Q2; $7.5B of Federal funding appropriated for EV infrastructure.

FET

Increasing global energy demand will propel long-term investment
Global footprint and strategy execution will drive strong free cash flow

BENF

Innovative access to private equity investments via public equity stock
Transitioned to GAAP net income profitable operations in F1Q 2025 (June 30 Quarter End)

IMRN

September 2024 Quarter AUD$1.5 million up 13% on prior quarter
Sales of Travelan® increased 3% to AUD $1.007 million during September 2024 Quarter

LMFA

Held 142.3 Bitcoin on September 30, 2024, Valued at Approximately $12.4 Million Based on Recent Bitcoin Price of $87,000
Digital mining cost of revenues (exclusive of depreciation and amortization) as a percentage of digital mining revenues showed substantial improvement versus the prior year quarter.

ACON

Industry 1st noninvasive diagnostic with strong clinical evidence of value
Nearly 60% of all patients with private health insurance in the greater London market now have Access to Aclarion’s Nociscan

AUUD

Leading the audio superapp space with differentiation & margin
Accretive M&A strategy to accelerate revenue & user acquisitions

SNGX

Robust pipeline with multiple fast track and/or orphan designated products, potential for significant commercial returns
Late clinical-stage assets, one with successful Phase 3 data readout

CPSH

Unique applications in rapidly-expanding markets
Strong balance sheet
New contract wins
At inflection point for growth

ASNS

Actelis is growing as the results of the year to-date can attest to, showing nearly 50% growth year over year, gross margin grew and net loss/EBITDA shrunk dramatically.
The company is expanding its reach into several segments such as cyber security of IoT devices in roads, cities, and more as well as multi-dwelling units

PERF

Industry growth potential in beauty/fashion tech
PERF's strength and innovations for growth in B2B (SAAS) and B2C (suite of apps under YouCam brand).

ULY

Leading proprietary digitally native mobility services platform
Uniquely positioned to further penetrate $25B B2B incident business opportunity

PLUR

$10m raise in EverAfter Foods from Global Food Giants as Strategic Partners
Innovative collaborations with multi-national agriculture corporations - €1 million POC project

SPGC

3Q24 revenue +1163% YOY and +48% QoQ
Newton Motion replacement shafts is company's key product line and is showing significant growth and even gaining traction with professional golfers.

HLRTF

A clean technology company developing high value, high performance power conversion
Technologies for next-generation powertrains and grid-connected renewable energy systems

The Speakers

Connecting Microcap Companies with Leading Investors

Why We Are Better

GATED AND VETTED

0 deal guys and 0 service providers

ACTUAL RESULTS

8 truly qualified meetings per company

37 presentation views + thousands of newsletter impressions post event

CONCIERGE SERVICE

The experience is a light lift for the presenting companies. Our investors show up and come prepared.

INTENT

At vendor events, meetings are often favors. Meetings with us are a result of true intent to buy on the open market.

WE ARE INDEPENDENT

We only focus on providing companies with high quality service and do not sell anything else after the event.

Virtual Event Format

Who Participates

Market Cap

$0 – $50M (37%)

$50 – $100M (41%)

$100 – $300 (13%)

$300+ (9%)

Sector

Healthcare (25%)

Consumer/Financial (23%)

Technology (22%)

Energy/Cannabis (16%)

Industrial/Blockchain (14%)

Investor Breakdown

Family Office (12%)

Institutional (61%)

HNW (9%)

RIAs (18%)

We participated in the virtual Summer Summit with a micro-cap client of ours, VIQ Solutions, Inc. We were very pleased to see that we had a full book of meetings for 3 of the four days of the event. The meetings were high quality and we've since had several follow-up meetings. We would definitely recommend the Summit for any micro or nano-cap company that's looking for HNW, accredited retail and family office investors.

Fred Rockwell and his team at Investor Summit Group put on world class investor events. The Investor Summit conferences are typically well-attended, thoughtfully organized, and provide a valuable opportunity to meet with many high quality management teams in a short amount of time. Looking forward to future conferences.

When JetPay first began our IR outreach, the MicroCap Conference (now the Investor Summit) was one of the first at which we participated. It is the only one we continued to attend each year, because of the quality of investor audience, presentation attendance, and overall setup. There is no question in our mind that this helped JetPay maintain our stock price and NASDAQ listing, allowing us to sell JetPay to NCR at a 168% premium to our share price at closing. We would recommend this conference to any small-cap company in our vertical markets.

We truly enjoyed the event and met with a number of high-quality investors that we intend to continue dialogue with. We look forward to participating in future events that you host. Thanks for putting on such a high-quality conference, we’ll be sure to let industry colleagues know of how valuable our opportunity was.

As always, the Investor Summit is very well-run and scheduled, with a wide variety of attendees. We feel we receive great value for the investment in the conference with the exposure we receive to new and existing investors.

While many investor conferences have transitioned to virtual format in recent weeks, The Investor Summit was far more of a success than others. I had a full slate of 1X1s, a well-attended presentation and no issues with the conferencing lines or other virtual aspects of the conference. I’m looking forward to the next Investor Summit conference.

Winter 2024 Investor Summit Virtual

Q4 Presenters

The Speakers

Lavall Chichester

Greg Falesnik

Fred Rockwell

Jordan Darrow

Valter Pinto

Dr. John Roy

Chuck Bennett

Kirin Smith

Nate Tobik

Curtis Shauger

Andrew Shapiro

Destiny Hance

Paul Antico

Yaky Yanay